SUBSTITUEREDE HETEROARYLAMIDANALOGER SOM MGLUR5-NEGATIVE ALLOSTERISKE MODULATORER OG FREMGANGSMÅDER TIL FREMSTILLING OG ANVENDELSE DERAF

摘要

Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.